|
|
Recalculation of warrants of series TO 2 following rights issue |
|
|
Nevisense (EIS) included in updated German (S1) imaging guidelines. |
|
|
SciBase announces final outcome of directed issue and rights issue |
|
|
SciBase announces outcome of directed issue and preliminary outcome of rights issue |
|
|
The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot |
|
|
Today the subscription period in SciBase rights issue begins |
|
|
SciBase letter from the CEO |
|
|
SciBase publishes prospectus |
|
|
Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) |
|
|
SciBase Announces Positive Findings in Case Study Monitoring Treatment Outcomes in Atopic Dermatitis Patient |
